Ozempic (semaglutide recalls

The FDA has published 1 recall involving Ozempic (semaglutide since 2021. The latest was reported on 21 Apr 2021. Most were for temperature abuse. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls1since 2021

Last 12 months0reported

Class I00% of total

Ongoing0latest 21 Apr 2021

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 1 100%Class III 0 0%

Why ozempic (semaglutide is recalled

Temperature Abuse1100%

Companies

Novo Nordisk1100%

By year

20211100%

All ozempic (semaglutide recalls, newest first

1 total

Reported	Class	Recall	Company	Reason	Where
21 Apr 2021Drug	CLASS II	Ozempic (semaglutide) injection, 2 mg recalled by Novo Nordisk	Novo Nordisk	Temperature Abuse	Nationwide

Should you stop taking Ozempic (semaglutide?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.